pembrolizumab
merck
['keytruda', 'merck']
 's #keytruda failed to provide benefit for the tki-resistant, egfr-mutant subtype of the disease.
#keytruda #merck #drugdevelopment #pharma #biospace 
Your source for biopharma news and jobs